Galectin Therapeutics Stock (NASDAQ: GALT) stock price, news, charts, stock research, profile.
You can purchase shares of Galectin Therapeutics (NASDAQ:GALT) through any online brokerage.
Other companies in Galectin Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), Immuneering (NASDAQ:IMRX) and Armata Pharmaceuticals (AMEX:ARMP).
There is no analysis for Galectin Therapeutics to provide a consensus price target.
The stock price for Galectin Therapeutics (NASDAQ: GALT) is $1.1398 last updated January 8, 2025 at 6:11 PM EST.
There are no upcoming dividends for Galectin Therapeutics.
Galectin Therapeutics’s Q4 earnings are confirmed for Friday, March 28, 2025.
There is no upcoming split for Galectin Therapeutics.
Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.